record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to staterecord state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding typeNo entity list is declared.
evidence
source-boundtheoretical · manual state transition
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition
evidence type
theoretical
conditions
Provenance
source title
Majzner et al. 2022 Nature
authors
reviewer:will-blair
GD2-CAR T cells administered intravenously and/or intracerebroventricularly achieve clinical and radiographic responses in 3 of 4 H3K27M DIPG patients in a phase I trial, without on-target off-tumor toxicity.
vs_7c5038ffa861a48d · manual_curation
outgoing
No outgoing links.
incoming
contradicts · vf_2d3e414ec9d8e6b9
extends · vf_fb5016c2f917c1b4
events
vev_ffa1fe767a0b82a8finding.assertedManual finding added to frontier state
reviewer:will-blair · 2026-05-29
reviewable changes
vpr_b0b4a83960e30990finding.addManual finding added to frontier state
applied · reviewer:will-blair · 2026-05-29
evaluations
No evaluation record targets this finding id.